It may be possible to collect nearly three times as many stem cells for gene therapy for sickle cell disease (SCD) with ...
In a society that often treats those living with a disability as "less than," columnist Mary Shaniqua reminds her community ...
An unfortunate reality is that life costs more when you are disabled. Why is this? Simply put, living with a disability often ...
For all of its challenges, living with sickle cell has offered columnist Oluwatosin Adesoye resilience, empathy, support, and ...
BEAM-101, a gene-editing stem cell therapy, showed early signs of efficacy among the first treated sickle cell patients in a ...
A University of Rochester hospital will open a patient study comparing the efficacy of SCD treatments to help families in ...
AB Science said it received a notice of allowance from the European Patent Office for a patent covering the use of the experimental oral therapy masitinib to treat sickle cell disease (SCD). The ...
Editas Medicine announced proof-of-concept data for a gene-editing approach for sickle cell disease that doesn't need a stem ...
The FDA granted orphan drug status to Kind Pharmaceuticals' investigational oral small molecule AND017 to treat SCD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback